In one paragraphArticle in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Soeun ParkDepartment of Senior Healthcare Major in Biopharmaceuticals and Major in Cosmetic Science, Eulji University, Seongnam-si 13153, Republic of Korea.
Saitbyul ParkAdvanced Beauty Science Research Division, AMOREPACIFIC Research & Innovation Center, Yongin-si 17074, Republic of Korea.ORCID 0000-0003-3278-9539 Nok Hyun ParkAdvanced Beauty Science Research Division, AMOREPACIFIC Research & Innovation Center, Yongin-si 17074, Republic of Korea.
Eun-Soo LeeAdvanced Beauty Science Research Division, AMOREPACIFIC Research & Innovation Center, Yongin-si 17074, Republic of Korea.
Kilsun MyoungAdvanced Beauty Science Research Division, AMOREPACIFIC Research & Innovation Center, Yongin-si 17074, Republic of Korea.
Heung-Soo BaekAdvanced Beauty Science Research Division, AMOREPACIFIC Research & Innovation Center, Yongin-si 17074, Republic of Korea.
Jaewoo JangCutisBio Research & Development Center, Seoul 06025, Republic of Korea.
Sang-Jip NamDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Republic of Korea.ORCID 0000-0002-0944-6565 Jaeyoung KoAdvanced Beauty Science Research Division, AMOREPACIFIC Research & Innovation Center, Yongin-si 17074, Republic of Korea.ORCID 0000-0003-3208-9794 Chang Seok LeeDepartment of Senior Healthcare Major in Biopharmaceuticals and Major in Cosmetic Science, Eulji University, Seongnam-si 13153, Republic of Korea.ORCID 0000-0002-4814-5685 Funding
Korea Health Industry Development Institute (KHIDI grant number: RS-2023-KH141100
6 · The paper itselfAbstract
Porphyra-334 (PPR-334) is one of the species of mycosporine-like amino acids (MAAs), known as biological UV protection ingredients. In this study, we developed a large-scale purification process to extract PPR-334 from
Indexed as
AntioxidantsSaccharomyces cerevisiaeSkinSkin AgingCatalaseCell ProliferationCyclohexanonesFibroblastsGlycation End Products, AdvancedGlycineHumansKeratinocytesMatrix Metalloproteinase 1NF-E2-Related Factor 2Reactive Oxygen SpeciesUltraviolet RaysAntioxidantsCatalaseCyclohexanonesGlycation End Products, AdvancedGlycineMatrix Metalloproteinase 1NF-E2-Related Factor 2porphyra-334Reactive Oxygen Speciesanti-agingantioxidanthuman artificial skin tissue modelshuman skin primary cellsporphyra-334UV
Identifiers
PMID41892957
PMCPMC13027577
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390